Development and evaluation of an algorithm to link mothers and infants in two US commercial healthcare claims databases for pharmacoepidemiology research.
Data linkage
Drug safety
Perinatal research
Pharmacoepidemiology
Real-world databases
Journal
BMC medical research methodology
ISSN: 1471-2288
Titre abrégé: BMC Med Res Methodol
Pays: England
ID NLM: 100968545
Informations de publication
Date de publication:
21 10 2023
21 10 2023
Historique:
received:
26
04
2023
accepted:
16
10
2023
medline:
1
11
2023
pubmed:
22
10
2023
entrez:
21
10
2023
Statut:
epublish
Résumé
Administrative healthcare claims databases are used in drug safety research but are limited for investigating the impacts of prenatal exposures on neonatal and pediatric outcomes without mother-infant pair identification. Further, existing algorithms are not transportable across data sources. We developed a transportable mother-infant linkage algorithm and evaluated it in two, large US commercially insured populations. We used two US commercial health insurance claims databases during the years 2000 to 2021. Mother-infant links were constructed where persons of female sex 12-55 years of age with a pregnancy episode ending in live birth were associated with a person who was 0 years of age at database entry, who shared a common insurance plan ID, had overlapping insurance coverage time, and whose date of birth was within ± 60-days of the mother's pregnancy episode live birth date. We compared the characteristics of linked vs. non-linked mothers and infants to assess similarity. The algorithm linked 3,477,960 mothers to 4,160,284 infants in the two databases. Linked mothers and linked infants comprised 73.6% of all mothers and 49.1% of all infants, respectively. 94.9% of linked infants' dates of birth were within ± 30-days of the associated mother's pregnancy episode end dates. Characteristics were largely similar in linked vs. non-linked mothers and infants. Differences included that linked mothers were older, had longer pregnancy episodes, and had greater post-pregnancy observation time than mothers with live births who were not linked. Linked infants had less observation time and greater healthcare utilization than non-linked infants. We developed a mother-infant linkage algorithm and applied it to two US commercial healthcare claims databases that achieved a high linkage proportion and demonstrated that linked and non-linked mother and infant cohorts were similar. Transparent, reusable algorithms applied to large databases enable large-scale research on exposures during pregnancy and pediatric outcomes with relevance to drug safety. These features suggest studies using this algorithm can produce valid and generalizable evidence to inform clinical, policy, and regulatory decisions.
Sections du résumé
BACKGROUND
Administrative healthcare claims databases are used in drug safety research but are limited for investigating the impacts of prenatal exposures on neonatal and pediatric outcomes without mother-infant pair identification. Further, existing algorithms are not transportable across data sources. We developed a transportable mother-infant linkage algorithm and evaluated it in two, large US commercially insured populations.
METHODS
We used two US commercial health insurance claims databases during the years 2000 to 2021. Mother-infant links were constructed where persons of female sex 12-55 years of age with a pregnancy episode ending in live birth were associated with a person who was 0 years of age at database entry, who shared a common insurance plan ID, had overlapping insurance coverage time, and whose date of birth was within ± 60-days of the mother's pregnancy episode live birth date. We compared the characteristics of linked vs. non-linked mothers and infants to assess similarity.
RESULTS
The algorithm linked 3,477,960 mothers to 4,160,284 infants in the two databases. Linked mothers and linked infants comprised 73.6% of all mothers and 49.1% of all infants, respectively. 94.9% of linked infants' dates of birth were within ± 30-days of the associated mother's pregnancy episode end dates. Characteristics were largely similar in linked vs. non-linked mothers and infants. Differences included that linked mothers were older, had longer pregnancy episodes, and had greater post-pregnancy observation time than mothers with live births who were not linked. Linked infants had less observation time and greater healthcare utilization than non-linked infants.
CONCLUSIONS
We developed a mother-infant linkage algorithm and applied it to two US commercial healthcare claims databases that achieved a high linkage proportion and demonstrated that linked and non-linked mother and infant cohorts were similar. Transparent, reusable algorithms applied to large databases enable large-scale research on exposures during pregnancy and pediatric outcomes with relevance to drug safety. These features suggest studies using this algorithm can produce valid and generalizable evidence to inform clinical, policy, and regulatory decisions.
Identifiants
pubmed: 37865728
doi: 10.1186/s12874-023-02073-6
pii: 10.1186/s12874-023-02073-6
pmc: PMC10590518
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
246Informations de copyright
© 2023. BioMed Central Ltd., part of Springer Nature.
Références
Am J Obstet Gynecol. 2011 Jul;205(1):51.e1-8
pubmed: 21514558
Epilepsia. 2004 Nov;45(11):1463-4
pubmed: 15509250
Pharmaceut Med. 2021 Jan;35(1):39-47
pubmed: 33369725
BMJ Open. 2014 Feb 17;4(2):e004365
pubmed: 24534260
J Allergy Clin Immunol. 1999 Feb;103(2 Pt 2):S362-3
pubmed: 9949340
Pharmacoepidemiol Drug Saf. 2022 Aug;31(8):863-874
pubmed: 35622900
Pharmacoepidemiol Drug Saf. 2017 Feb;26(2):208-214
pubmed: 28028914
N Engl J Med. 2006 Jun 8;354(23):2443-51
pubmed: 16760444
Epilepsia. 2010 May;51(5):909-15
pubmed: 20196792
PLoS One. 2018 Feb 1;13(2):e0192033
pubmed: 29389968
J Clin Epidemiol. 2013 Aug;66(8 Suppl):S84-S90.e1
pubmed: 23849158
Clin Epidemiol. 2020 Oct 15;12:1129-1138
pubmed: 33116906
Pharmacoepidemiol Drug Saf. 2019 Sep;28(9):1222-1230
pubmed: 31286606
J Womens Health (Larchmt). 2015 Nov;24(11):924-32
pubmed: 26244900
Pharmacoepidemiol Drug Saf. 2016 Feb;25(2):170-8
pubmed: 26599424
Drug Saf. 2004;27(4):215-28
pubmed: 15003034
N Engl J Med. 2014 Jun 19;370(25):2397-407
pubmed: 24941178
Congenit Anom (Kyoto). 2011 Mar;51(1):6-11
pubmed: 21158950
Stat Med. 2009 Nov 10;28(25):3083-107
pubmed: 19757444
Pharmacoepidemiol Drug Saf. 2011 Mar;20(3):258-64
pubmed: 21351307
J Am Med Inform Assoc. 2015 May;22(3):553-64
pubmed: 25670757
Pharmacoepidemiol Drug Saf. 2015 Jan;24(1):45-51
pubmed: 25408418
JAMA Psychiatry. 2018 Feb 1;75(2):167-175
pubmed: 29238795
J Clin Res Bioeth. 2011 Mar 31;2(108):
pubmed: 21863146
Birth Defects Res A Clin Mol Teratol. 2009 Jan;85(1):93-101
pubmed: 19107953
Int J Epidemiol. 2021 Nov 10;50(5):1416-1417h
pubmed: 34097034
JAMA Health Forum. 2021 Jul 23;2(7):e211652
pubmed: 35977209
Pharmacoepidemiol Drug Saf. 2009 Aug;18(8):737-42
pubmed: 19504626
Pharmacoepidemiol Drug Saf. 2020 Jan;29(1):9-17
pubmed: 31736248
Ann Intern Med. 2018 Nov 20;169(10):665-673
pubmed: 30326014
PLoS One. 2023 Apr 24;18(4):e0284893
pubmed: 37093890
Am J Obstet Gynecol MFM. 2022 Jan;4(1):100512
pubmed: 34656737
Pharmacoepidemiol Drug Saf. 2019 Jul;28(7):906-922
pubmed: 31074570
Teratology. 2000 Dec;62(6):385-92
pubmed: 11091360
Pediatrics. 2017 Jul;140(1):
pubmed: 28759401
J Am Med Inform Assoc. 2012 Jan-Feb;19(1):54-60
pubmed: 22037893
Curr Epidemiol Rep. 2014 Dec;1(4):175-185
pubmed: 26085977
J Korean Med Sci. 2018 Mar 05;33(10):e80
pubmed: 29495143
J Clin Epidemiol. 2005 Apr;58(4):323-37
pubmed: 15862718
Stud Health Technol Inform. 2015;216:574-8
pubmed: 26262116
Reprod Toxicol. 2008 Oct;26(2):175-7
pubmed: 18640262
J Am Med Inform Assoc. 2023 Apr 19;30(5):859-868
pubmed: 36826399
Pharmacoepidemiol Drug Saf. 2015 May;24(5):510-7
pubmed: 25833769
J Popul Ther Clin Pharmacol. 2010 Fall;17(3):e336-40
pubmed: 21041866
JAMA. 2016 Apr 26;315(16):1750-66
pubmed: 27063997
Matern Child Health J. 2015 Sep;19(9):2081-8
pubmed: 25707488
PLoS One. 2013 Jun 26;8(6):e67405
pubmed: 23840692
Clin Pharmacol Ther. 2012 Aug;92(2):149-50
pubmed: 22814658
Womens Health Issues. 2013 Jan;23(1):e39-45
pubmed: 23312713
Matern Child Health J. 2012 Oct;16(7):1349-54
pubmed: 22002179
Curr Epidemiol Rep. 2017;4(2):106-116
pubmed: 29399433
J Med Econ. 2015;18(7):533-41
pubmed: 25714263